|
"Cancer Information Service"
|
N02CO511014-003
|
$653,527
|
ISSELL, BRIAN
|
University of Hawaii
|
|
"Cancer Information Service"
|
N02CO511000-003
|
$961,822
|
DEVITA, VINCENT
|
Yale University Inc
|
|
"Regulation of Glioma Cell Apoptosis in PKCDelta"
|
5R01CA109196-03
|
$242,696
|
BRODIE, CHAYA
|
HENRY FORD HEALTH SYSTEM
|
|
1H-Nuclear Magnetic Resonance Spectroscopic Imaging of the Brain in Patients who
|
Z01 BC 010581
|
$34,098
|
Warren, Katherine
|
CCR (NCI)
|
|
2nd Symposium on Polyomaviruses and Human Disease
|
5R13CA110760-03
|
$10,000
|
ATWOOD, WALTER
|
BROWN UNIVERSITY
|
|
4-Peroxycyclophosphamides for Brain Tumor Therapy
|
5R01CA100074-04
|
$217,702
|
STRUCK, ROBERT
|
CANCERMEDICA, LLC
|
|
A Comparative Study of Pediatric CNS Tumor Activity as Assessed by[18F-]- FDG PET
|
Z01 BC 010582
|
$34,098
|
Warren, Katherine
|
CCR (NCI)
|
|
A Diffusion-Based MRI Method to Detect Glioma Invasion
|
1R21CA109280-01A1
|
$181,800
|
SCHMAINDA, KATHLEEN
|
MEDICAL COLLEGE OF WISCONSIN
|
|
A Novel Device to Allow Zoom-In Imaging for PET Scanners
|
5R33CA110011-04
|
$321,582
|
TAI, YUAN-CHUAN
|
WASHINGTON UNIVERSITY
|
|
A Phase I Trial of CC-5013 (lenalidomide) in Pediatric Patients with Recurrent or
|
Z01 BC 010585
|
$17,049
|
Warren, Katherine
|
CCR (NCI)
|
|
A Pilot Study of 1H-Nuclear Magnetic Resonance Spectroscopic Imaging in Pediatric
|
Z01 BC 010584
|
$34,098
|
Warren, Katherine
|
CCR (NCI)
|
|
A proteomics approach to ubiquitination
|
5R21CA126222-02
|
$200,560
|
PENG, JUNMIN
|
EMORY UNIVERSITY
|
|
Abramson Cancer Center of the U of P Core Support Grant
|
3P30CA016520-32S1
|
$215,193
|
THOMPSON, CRAIG
|
UNIVERSITY OF PENNSYLVANIA
|
|
Abramson Cancer Center of the U of P Core Support Grant
|
5P30CA016520-32
|
$7,282,327
|
Thompson, Craig
|
UNIVERSITY OF PENNSYLVANIA
|
|
AKT2 Oncogene and Human Oncogenesis
|
5R01CA077935-10
|
$228,571
|
CHENG, JIN
|
H. LEE MOFFITT CANCER CTR & RES INST
|
|
Allergies, Genetic Susceptibility and Adult Glioma Risk
|
5R01CA114205-02
|
$399,509
|
MICHAUD, DOMINIQUE
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Allogeneic glioma vaccine using TGF-beta knockouts
|
4R44CA105964-02
|
$810,121
|
FAKHRAI, HABIB
|
NOVARX CORPORATION
|
|
American College of Radiology Imaging Network
|
5U01CA080098-09
|
$10,637,601
|
HILLMAN, BRUCE
|
AMERICAN COLLEGE OF RADIOLOGY
|
|
An Exploratory Study of Biologic and Pathophysiologic Efects of Radiation Therap
|
Z01 BC 010709
|
$34,098
|
Warren, Katherine
|
CCR (NCI)
|
|
An investigation of radial glia as the source of ependymoma stem cells
|
1R01CA129541-01
|
$313,500
|
Gilbertson, Richard
|
ST. JUDE CHILDREN'S RESEARCH HOSPITAL
|
|
Analyses of the Molecular Functions for D-Cyclins
|
5R01CA108420-04
|
$337,111
|
SICINSKI, PIOTR
|
DANA-FARBER CANCER INSTITUTE
|
|
Analysis of a 10Q Tumor Suppressor Gene
|
5R01CA056041-15
|
$286,350
|
Yung, W K
|
UNIVERSITY OF TEXAS MD ANDERSON CAN CTR
|
|
Analysis of the VHL-HIF hydroxylase pathway
|
1R01CA125020-01A1
|
$221,920
|
SHIIO, YUZURU
|
UNIVERSITY OF TEXAS HLTH SCI CTR SAN ANT
|
|
Anatomic Pathology Residency Program
|
Z01 BC 010684
|
$1,395,646
|
Jaffe, Elaine
|
CCR (NCI)
|
|
Angiogenic Factors Associated with Uveal Melanoma
|
5R01CA103653-07
|
$376,608
|
POLANS, ARTHUR
|
UNIVERSITY OF WISCONSIN MADISON
|
|
Angiopoietin-2 and Glioma Invasion
|
5R01CA102011-04
|
$288,651
|
CHENG, SHI-YUAN
|
UNIVERSITY OF PITTSBURGH AT PITTSBURGH
|
|
Ape1, oxidative stress and glioma alkylator resistance
|
5R01CA104593-04
|
$283,920
|
SILBER, JOHN
|
UNIVERSITY OF WASHINGTON
|
|
Apoptosis Mechanisms and Human Cancer
|
5R01CA082197-08
|
$262,741
|
WANG, HONG-GANG
|
H. LEE MOFFITT CANCER CTR & RES INST
|
|
Arizona Cancer Center Support Grant
|
3P30CA023074-30S1
|
$363,313
|
ALBERTS, DAVID
|
UNIVERSITY OF ARIZONA
|
|
Arizona Cancer Center Support Grant
|
3P30CA023074-30S2
|
$113,227
|
ALBERTS, DAVID
|
UNIVERSITY OF ARIZONA
|
|
Arizona Cancer Center Support Grant
|
3P30CA023074-30S3
|
$327,884
|
ALBERTS, DAVID
|
UNIVERSITY OF ARIZONA
|
|
Arizona Cancer Center Support Grant
|
3P30CA023074-30S4
|
$88,172
|
ALBERTS, DAVID
|
UNIVERSITY OF ARIZONA
|
|
Arizona Cancer Center Support Grant
|
5P30CA023074-30
|
$4,124,404
|
ALBERTS, DAVID
|
UNIVERSITY OF ARIZONA
|
|
Assessment and Optimization for Radiation Therapy
|
5R01CA050628-18
|
$373,347
|
NIEMIERKO, ANDRZEJ
|
MASSACHUSETTS GENERAL HOSPITAL
|
|
Astatine and Iodine Radiolabeled Monoclonal Antibodies
|
5R37CA042324-22
|
$449,089
|
ZALUTSKY, MICHAEL
|
DUKE UNIVERSITY
|
|
Astrocytic Cancers: How, When, Where?
|
5U01CA084314-09
|
$1,087,426
|
VAN DYKE, TERRY
|
UNIVERSITY OF NORTH CAROLINA CHAPEL HILL
|
|
Atlanta Regional Community Clinical Oncology Program
|
5U10CA045450-21
|
$623,000
|
SEAY, THOMAS
|
ST. JOSEPH'S HOSPITAL
|
|
AZD2171 and chemoradiation for newly diagnosed glioblastoma
|
1R01CA129371-01
|
$552,172
|
Batchelor, Tracy
|
MASSACHUSETTS GENERAL HOSPITAL
|
|
BAALC in neurogenesis and hematopoiesis
|
5R01CA098933-04
|
$290,595
|
DE LA CHAPELLE, ALBERT
|
OHIO STATE UNIVERSITY
|
|
Bay Area Tumor Institute CCOP
|
2U10CA045461-18
|
$480,000
|
FEUSNER, JAMES
|
BAY AREA TUMOR INSTITUTE
|
|
Bayesian Models for Gene Expression with Microarray Data
|
5R01CA104620-03
|
$272,472
|
MALLICK, BANI
|
TEXAS A&M UNIVERSITY SYSTEM
|
|
Baylor College of Medicine Cancer Center
|
1P30CA125123-01
|
$1,500,000
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
Baylor College of Medicine Cancer Center
|
3P30CA125123-01S1
|
$111,700
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
Beaumont Community Clinical Oncology Program
|
5U10CA095860-06
|
$1,030,000
|
DECKER, DAVID
|
WILLIAM BEAUMONT HOSPITAL RESEARCH INST
|
|
bHLH Factors in Medulloblastoma Genesis and Maintenance
|
5R01CA112350-03
|
$310,300
|
OLSON, JAMES
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Biodegradable Targeted Nanoparticle for Delivery of Radiosensitizer to Rat Glioma
|
5R43CA119578-03
|
$209,884
|
REDDY, G
|
NEXT GENERATION THERAPEUTICS, INC.
|
|
Biology of SV40-Specific Transplantation Antigen
|
5R01CA025000-30
|
$631,071
|
SCHELL, TODD
|
PENNSYLVANIA STATE UNIV HERSHEY MED CTR
|
|
Biomarker Studies for Novel Anti-Cancer Agents
|
5U01CA099118-05
|
$62,170
|
COLVIN, OLIVER
|
DUKE UNIVERSITY
|
|
Biomodulation of anticancer drugs targeting DNA
|
1R01CA116491-01A2
|
$228,000
|
CARRIER, FRANCE
|
UNIVERSITY OF MARYLAND BALTIMORE
|
|
BIOSYNTHETIC KEY STEPS OF ANGUCYCLINE ANTITUMOR DRUGS
|
5R01CA102102-03
|
$246,853
|
ROHR, JURGEN
|
UNIVERSITY OF KENTUCKY
|
Relevant funding data is only available when one cancer type or one research topic is selected.
|